Bridion 200 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AX8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,470
Award facts
- Contract value 100% obligated
- $18,470.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,470.47 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price contract, which was competitively awarded without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Bridion (sugammadex) is a neuromuscular blocking agent reversal medication used in surgical and anesthesia settings, representing the type of specialized pharmaceutical product essential to military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999.999 billion through December 2031. This comprehensive IDC vehicle enables the supply of a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and medical devices to support military treatment facilities and veteran healthcare programs globally. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills such specialized pharmaceutical requirements across multiple therapeutic domains through its established federal contract infrastructure.
Quick answers
Who was awarded contract SPE2DR26F1AX8?
SPE2DR26F1AX8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1AX8 worth?
The government has obligated $18,470 on SPE2DR26F1AX8.
Is contract SPE2DR26F1AX8 an order under another contract?
Yes. SPE2DR26F1AX8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AX8 competed?
The extent of competition for SPE2DR26F1AX8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award